Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
Recruiting
100 enrolled
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Recruiting
500 enrolled
Biobank for Cholestatic Liver Diseases.
Recruiting
9,150 enrolled
Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
Recruiting
300 enrolled
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Recruiting
1,800 enrolled
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Recruiting
1,200 enrolled
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
Recruiting
500 enrolled
FAPi-2
Recruiting
60 enrolled
Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA
Recruiting
50 enrolled
PROTEOBILE
Recruiting
200 enrolled
Molecular Epidemiology of Biliary Tree Cancers
Recruiting
1,500 enrolled
A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
Recruiting
1,800 enrolled
TraveraRTGx
Recruiting
200 enrolled
FFCD-2205
Recruiting
150 enrolled
An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.
Recruiting
308 enrolled
ISTAR-03
Recruiting
60 enrolled
D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC
Recruiting
37 enrolled
Bile Omics for Diagnosing Indeterminate Biliary Strictures
Recruiting
260 enrolled
BILLIONSTARS
Recruiting
150 enrolled
JADE
Recruiting
1,000 enrolled
Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.
Recruiting
53 enrolled
VOCAL2
Recruiting
750 enrolled
INSPIRE
Recruiting
5,350 enrolled
Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma
Recruiting
300 enrolled
ROBOCHOL
Recruiting
32 enrolled
RETUD
Recruiting
20,000 enrolled
GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC
Recruiting
21 enrolled
CHC/CC
Recruiting
1,250 enrolled
Prognostic Factors for Survival in Patients With Cholangiocarcinoma
Recruiting
2,000 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Recruiting
2,700 enrolled
ERDB
Recruiting
1,000 enrolled
LEATUM
Recruiting
580 enrolled
Liver Transplantation in Intrahepatic Cholangiocarcinoma
Recruiting
30 enrolled
The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
Recruiting
1,000 enrolled
DELPHI
Recruiting
100 enrolled